Key facts
- ProteanTecs’s last known valuation is $449.6M (May 2022).
- It has raised $241.5M; the latest was Later Stage VC ($51.0M) in Mar 2026.
- Notable investors include Mitsubishi UFJ Capital, Valor Equity Partners, Intel Capital, Avenir Growth Capital, Addition — 26 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 26 names
- ·Watchlist + deal alerts for ProteanTecs
- ·The full record, as it builds
Funding rounds
No funding rounds for ProteanTecs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ProteanTecs
Developer of an analytics platform designed to increase the performance and reliability of electronic systems. The company's cloud-based platform combines data created in chip-embedded agents with machine learning, enabling manufacturers to increase the performance and quality, making electronics more predictable, safer, and reliable for customers.
- Sector
- Information Technology
- HQ
- Haifa, Israel
- Founded
- 2017
- Employees
- 200
- Website
- proteantecs.com/
- Ownership
- Privately Held (backing)
ProteanTecs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ProteanTecs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ProteanTecs in its N-PORT filings yet. We sweep new filings monthly.